Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Xencor Retained Earnings (Accumulated Deficit) 2012-2024 | XNCR

Xencor retained earnings (accumulated deficit) from 2012 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
  
Xencor Annual Retained Earnings (Accumulated Deficit)
(Millions of US $)
2024 $-704
2023 $-471
2022 $-338
2021 $-283
2020 $-366
2019 $-296
2018 $-323
2017 $-253
2016 $-238
2015 $-262
2014 $-244
2013 $-228
2012 $-167
2011 $-159
Xencor Quarterly Retained Earnings (Accumulated Deficit)
(Millions of US $)
2024-12-31 $-704
2024-09-30 $-658
2024-06-30 $-612
2024-03-31 $-545
2023-12-31 $-471
2023-09-30 $-445
2023-06-30 $-421
2023-03-31 $-399
2022-12-31 $-338
2022-09-30 $-326
2022-06-30 $-293
2022-03-31 $-260
2021-12-31 $-283
2021-09-30 $-356
2021-06-30 $-316
2021-03-31 $-368
2020-12-31 $-366
2020-09-30 $-352
2020-06-30 $-339
2020-03-31 $-304
2019-12-31 $-296
2019-09-30 $-269
2019-06-30 $-259
2019-03-31 $-243
2018-12-31 $-323
2018-09-30 $-305
2018-06-30 $-308
2018-03-31 $-282
2017-12-31 $-253
2017-09-30 $-275
2017-06-30 $-260
2017-03-31 $-253
2016-12-31 $-238
2016-09-30 $-229
2016-06-30 $-221
2016-03-31 $-268
2015-12-31 $-262
2015-09-30 $-269
2015-06-30 $-259
2015-03-31 $-250
2014-12-31 $-244
2014-09-30 $-243
2014-06-30 $-236
2014-03-31 $-231
2013-12-31 $-228
2013-09-30 $-224
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2011-12-31 $-159
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.753B $0.110B
Xencor Inc. is a clinical-stage biopharmaceutical company. It develops antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer. Xencor Inc. is based in Monrovia, California.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $93.202B 34.96
Zoetis (ZTS) United States $69.350B 26.25
Takeda Pharmaceutical (TAK) Japan $48.619B 10.76
Daiichi Sankyo, - (DSNKY) Japan $47.708B 24.27
Sandoz Group AG (SDZNY) Switzerland $19.609B 0.00
Astellas Pharma (ALPMY) Japan $18.241B 10.72
Merck (MKKGY) Germany $17.913B 14.82
Summit Therapeutics (SMMT) United States $17.424B 0.00
Shionogi (SGIOY) Japan $14.411B 14.44
United Therapeutics (UTHR) United States $13.508B 12.23
Neurocrine Biosciences (NBIX) United States $10.610B 32.60
IPSEN (IPSEY) France $9.463B 0.00
Orion OYJ (ORINY) Finland $8.841B 23.91
Corcept Therapeutics (CORT) United States $7.766B 59.06
Madrigal Pharmaceuticals (MDGL) United States $7.525B 0.00
Stevanato Group S.p.A (STVN) Italy $6.360B 40.38
Ono Pharmaceutical (OPHLF) Japan $5.988B 12.26
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.813B 0.00
Grifols, S.A (GRFS) Spain $4.868B 0.00
Ionis Pharmaceuticals (IONS) United States $4.739B 0.00
Soleno Therapeutics (SLNO) United States $3.757B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.119B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.961B 12.02
Hypermarcas (HYPMY) Brazil $2.534B 16.67
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.402B 14.90
Recursion Pharmaceuticals (RXRX) United States $2.299B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.037B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.827B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.766B 0.00
Indivior (INDV) United States $1.620B 6.87
Guardian Pharmacy Services (GRDN) United States $1.525B 0.00
Evotec AG (EVO) Germany $1.516B 0.00
ARS Pharmaceuticals (SPRY) United States $1.366B 174.00
Dyne Therapeutics (DYN) United States $1.332B 0.00
Ocular Therapeutix (OCUL) United States $1.306B 0.00
Ardelyx (ARDX) United States $1.299B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.110B 45.11
Enliven Therapeutics (ELVN) United States $0.915B 0.00
Harrow (HROW) United States $0.905B 0.00
Collegium Pharmaceutical (COLL) United States $0.887B 4.71
Avadel Pharmaceuticals (AVDL) Ireland $0.832B 0.00
AleAnna (ANNA) United States $0.790B 0.00
Cronos Group (CRON) Canada $0.713B 0.00
Xeris Biopharma Holdings (XERS) United States $0.690B 0.00
KalVista Pharmaceuticals (KALV) United States $0.650B 0.00
Bioventus (BVS) United States $0.619B 16.08
Organogenesis (ORGO) United States $0.619B 0.00
Akebia Therapeutics (AKBA) United States $0.574B 0.00
Savara (SVRA) United States $0.563B 0.00
Relay Therapeutics (RLAY) United States $0.529B 0.00
USANA Health Sciences (USNA) United States $0.526B 11.29
Verve Therapeutics (VERV) United States $0.487B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.475B 0.00
Elite Pharmaceuticals (ELTP) United States $0.440B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.437B 0.00
Tourmaline Bio (TRML) United States $0.418B 0.00
Siga Technologies (SIGA) United States $0.412B 7.02
Zevra Therapeutics (ZVRA) United States $0.395B 0.00
Altimmune (ALT) United States $0.393B 0.00
Oruka Therapeutics (ORKA) United States $0.391B 0.00
Heron Therapeutics (HRTX) United States $0.356B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.350B 20.82
CytoDyn (CYDY) United States $0.316B 0.00
ProKidney (PROK) United States $0.316B 0.00
Aquestive Therapeutics (AQST) United States $0.282B 0.00
Avita Medical (RCEL) United States $0.264B 0.00
OmniAb (OABI) United States $0.226B 0.00
Regulus Therapeutics (RGLS) United States $0.223B 0.00
Nature's Sunshine Products (NATR) United States $0.221B 26.02
Wellgistics Health (WGRX) United States $0.209B 0.00
MediWound (MDWD) Israel $0.196B 0.00
Esperion Therapeutics (ESPR) United States $0.190B 24.00
Journey Medical (DERM) United States $0.174B 0.00
Inhibikase Therapeutics (IKT) United States $0.167B 0.00
Aldeyra Therapeutics (ALDX) United States $0.161B 0.00
Korro Bio (KRRO) United States $0.157B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.156B 0.00
Larimar Therapeutics (LRMR) United States $0.153B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.152B 47.01
4D Molecular Therapeutics (FDMT) United States $0.150B 0.00
Nanobiotix S.A (NBTX) France $0.148B 0.00
Profound Medical (PROF) Canada $0.147B 0.00
Aclaris Therapeutics (ACRS) United States $0.144B 0.00
Nektar Therapeutics (NKTR) United States $0.138B 0.00
Protara Therapeutics (TARA) United States $0.131B 0.00
Lyell Immunopharma (LYEL) United States $0.128B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.124B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Lexeo Therapeutics (LXEO) United States $0.119B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.112B 0.00
Champions Oncology (CSBR) United States $0.104B 17.09
VAXART, INC (VXRT) United States $0.097B 0.00
Cardiol Therapeutics (CRDL) Canada $0.095B 0.00
OptiNose (OPTN) United States $0.094B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.088B 0.00
Achieve Life Sciences (ACHV) Canada $0.084B 0.00
Arch Biopartners (ACHFF) Canada $0.081B 0.00
Context Therapeutics (CNTX) United States $0.079B 0.00
Galectin Therapeutics (GALT) United States $0.079B 0.00
ESSA Pharma (EPIX) Canada $0.079B 0.00
Unicycive Therapeutics (UNCY) United States $0.077B 0.00
Cassava Sciences (SAVA) United States $0.075B 0.00
Telomir Pharmaceuticals (TELO) United States $0.075B 0.00
Dominari Holdings (DOMH) United States $0.068B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.068B 0.00
Inotiv (NOTV) United States $0.066B 0.00
Pyxis Oncology (PYXS) United States $0.064B 0.00
Nutriband (NTRB) United States $0.063B 0.00
Assertio Holdings (ASRT) United States $0.063B 0.00
Fractyl Health (GUTS) United States $0.062B 0.00
Metagenomi (MGX) United States $0.062B 0.00
Vivani Medical (VANI) United States $0.061B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Karyopharm Therapeutics (KPTI) United States $0.054B 0.00
Gain Therapeutics (GANX) United States $0.054B 0.00
Avalo Therapeutics (AVTX) United States $0.053B 0.00
PMV Pharmaceuticals (PMVP) United States $0.052B 0.00
ElectroCore (ECOR) United States $0.051B 0.00
Prelude Therapeutics (PRLD) United States $0.051B 0.00
Mural Oncology (MURA) Ireland $0.045B 0.00
Acrivon Therapeutics (ACRV) United States $0.045B 0.00
Century Therapeutics (IPSC) United States $0.043B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.043B 0.00
Rafael Holdings (RFL) United States $0.042B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.041B 0.00
SCYNEXIS (SCYX) United States $0.039B 0.00
Iterum Therapeutics (ITRM) Ireland $0.037B 0.00
NRx Pharmaceuticals (NRXP) United States $0.035B 0.00
Surrozen (SRZN) United States $0.034B 0.00
FibroGen (FGEN) United States $0.033B 0.00
PolyPid (PYPD) Israel $0.027B 0.00
Tempest Therapeutics (TPST) United States $0.026B 0.00
CASI Pharmaceuticals (CASI) China $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.022B 0.00
VYNE Therapeutics (VYNE) United States $0.021B 0.00
Jupiter Neurosciences (JUNS) United States $0.021B 0.00
Mannatech (MTEX) United States $0.021B 8.29
DURECT (DRRX) United States $0.019B 0.00
Natural Alternatives (NAII) United States $0.019B 0.00
Lipocine (LPCN) United States $0.017B 0.00
Vivos Therapeutics (VVOS) United States $0.016B 0.00
BioVie (BIVI) United States $0.015B 0.00
GlycoMimetics (GLYC) United States $0.015B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.014B 0.00
MEI Pharma (MEIP) United States $0.013B 0.00
Plus Therapeutics (PSTV) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.012B 9.08
Scienture Holdings (SCNX) United States $0.012B 0.00
Cosmos Health (COSM) United States $0.011B 0.00
Ernexa Therapeutics (ERNA) United States $0.011B 0.00
BioLineRx (BLRX) Israel $0.011B 0.00
TransCode Therapeutics (RNAZ) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 3.16
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
Relmada Therapeutics (RLMD) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Nuvilex (PMCB) United States $0.009B 0.00
Carisma Therapeutics (CARM) United States $0.008B 0.00
Talphera (TLPH) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Ainos (AIMD) United States $0.008B 0.00
Jaguar Animal Health (JAGX) United States $0.008B 0.00
Lyra Therapeutics (LYRA) United States $0.008B 0.00
Indaptus Therapeutics (INDP) United States $0.008B 0.00
Citius Pharmaceuticals (CTXR) United States $0.007B 0.00
Traws Pharma (TRAW) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.005B 0.00
CERo Therapeutics Holdings (CERO) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Klotho Neurosciences (KLTO) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Conduit Pharmaceuticals (CDT) United States $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Incannex Healthcare (IXHL) Australia $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
SHINECO (SISI) China $0.001B 0.00
Heatwurx (PCSA) United States $0.001B 0.00
Petros Pharmaceuticals (PTPI) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00